Bullmarket.com Offers Investment Opinion on Niche Medical Testing Companies.PRINCETON, N.J. -- BullMarket.com (http://www.bullmarket.com), an online investment newsletter focused on long-term growth and income-generating stocks, announced today that it has provided subscribers with a report on niche medical testing companies, including Genoptix (Nasdaq: GXDX), Bio-Reference Laboratories (Nasadaq: BRLI BRLI Bio Rad Laboratories Inc ), and Nanosphere (Nasdaq: NSPH NSPH National Society of Professional Hypnotherapists (Scotland) ), among others. All paid and trial subscribers to BullMarket.com can now receive immediate access to the newsletter's exclusive daily reports. As a subscriber, you'll also gain access to our latest investment moves. Start your 14-day free trial today: https://www.bullmarket.com/subscribe/pr/?refer=BMR BMR basal metabolic rate. BMR abbr. basal metabolic rate BMR, n See basal metabolic rate. BMR basal metabolic rate. 377B In its report, BullMarket.com wrote: "Commercial medical testing is dominated by two companies, Quest Diagnostics (NYSE NYSE See: New York Stock Exchange : DGX) and Laboratory Corp. of America (NYSE: LH), but there are a lot of niche and regional players. One that caught our eye as an IPO (Initial Public Offering) The first time a company offers shares of stock to the public. While not a computer term per se, many founders, employees and insiders of computer companies have found this acronym more exciting than any tech term they ever heard. last year was California-based Genoptix. Another we recently uncovered is New Jersey-based Bio-Reference Laboratories." BullMarket.com looked at the following topics, among others: -- What drove top-line growth at Genoptix to nearly double during the second quarter? How does seasonality affect Genoptix's business, and how did the timing of seasonal influences benefit its second-quarter results? -- Although it has yet to turn a profit, is startup Nanosphere shaping up to be a quality investment or is it only a speculative play? -- Which specialty services represent growth opportunities for Bio-Reference Laboratories? How has Bio-Reference invested in these areas, and will this translate into stronger growth for the company in the future? -- Should investors buy shares of niche and regional medical testing companies, or are the two-top companies, Quest Diagnostics and Laboratory Corp., better investments? About BullMarket.com: Launched in 1997, BullMarket.com has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The BullMarket.com Recommended List includes about 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. BullMarket.com is one of the oldest continuously published investment newsletters online, and its Recommended List has consistently outperformed the major market indices. NOTE: This release was published by Indie Research Advisors, LLC (CRD CRD See Central Registration Depository (CRD). #131926), a registered investment advisor Registered Investment Advisor (RIA) is a designation obtainable in the United States by an individual who has registered with the U.S. Securities and Exchange Commission or state regulatory agency (where the primary business is situated or multiple States in some cases) in with the NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). and State of NJ. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion